Alzheimer's Disease and Animal Models

$38,621P50FY2005AGNIH

Johns Hopkins University, Baltimore MD

Investigators

Linked publications & trials

Paper 39713873 Paper 39711228 Paper 39677464 Paper 39606446 Paper 39484387 Paper 39464100 Paper 39379761 Paper 39254167 Paper 39231932 Paper 39207439 Paper 39173101 Paper 38980643 Paper 38958543 Paper 38958117 Paper 38949538 Paper 38942763 Paper 38915636 Paper 38883718 Paper 38840027 Paper 38823249 Paper 38721926 Paper 38712163 Paper 38641585 Paper 38460116 Paper 38441951 Paper 38425303 Paper 38423160 Paper 38418871 Paper 38327094 Paper 38264712 Paper 38244935 Paper 38230717 Paper 38194584 Paper 38185937 Paper 37801072 Paper 37742656 Paper 37592813 Paper 37580727 Paper 37561943 Paper 37528055 Paper 37491248 Paper 37474615 Paper 37322115 Paper 37293032 Paper 37260021 Paper 37256497 Paper 37245492 Paper 37243937 Paper 37212114 Paper 37057867 Paper 37051669 Paper 37038809 Paper 36997127 Paper 36970907 Paper 36946449 Paper 36840665 Paper 36758620 Paper 36744337 Paper 36722399 Paper 36710669 Paper 36681388 Paper 36648159 Paper 36628434 Paper 36621368 Paper 36617779 Paper 36577280 Paper 36565204 Paper 36564192 Paper 36530083 Paper 36482861 Paper 36394443 Paper 36324086 Paper 36314203 Paper 36308307 Paper 36264254 Paper 36253382 Paper 36251929 Paper 36220593 Paper 36189595 Paper 36178120 Paper 36097795 Paper 36093697 Paper 36062452 Paper 36031904 Paper 36031892 Paper 35894783 Paper 35871325 Paper 35842477 Paper 35841257 Paper 35797594 Paper 35768831 Paper 35699222 Paper 35640459 Paper 35551470 Paper 35551019 Paper 35531707 Paper 35513767 Paper 35452678 Paper 35444054 Paper 35439098

Abstract

[unreadable] DESCRIPTION (provided by applicant): The overall goal of the Johns Hopkins Alzheimer's Disease Research Center (ADRC) is to conduct research on Alzheimer's Disease (AD), and to provide shared resources that facilitate research in AD and related disorders throughout the Greater Baltimore area. The ADRC will continue to address basic research questions about the neurobiology of AD and also support clinical studies that are designed to further understanding of the earliest stages of AD, by focusing on differences between normal controls, subjects with Mild Cognitive Impairment (MCI) and patients with mild AD. The ADRC will also promote training opportunities for fellows and junior faculty so they can acquire research skills in both basic and clinical studies related to AD. The Center will also provide education to the lay public about AD and foster ways of improving health care delivery to patients with AD and related disorders. The Center will be comprised of five Cores: 1) an Administrative Core, 2) a Clinical Core, 3) a Statistics and Data Management Core, 4) a Neuropathology Core, and 5) an Education Core. These cores will work together to facilitate the longitudinal evaluation of: 1) normal controls, 2) subjects meeting criteria for MCI, 3) patients with mild AD, and 4) non- AD dementias. In addition, three projects are proposed that will focus on the earliest stages of AD, including 1) a project on executive function ability in normal controls, MCI and AD cases, 2) a project on clinicopathological correlations in normal controls, MCI and AD cases, and 3) a project on animal models of the earliest stages of AD, using several lines of transgenic mice. Cooperative activities with researchers in other [unreadable] centers around the country will also be encouraged, by sharing data and specimens obtained from subjects who have been evaluated through the Centers program. [unreadable] [unreadable]

View original record on NIH RePORTER →